Dr Peter Schulam, MD - Medicare Urology in New Haven, CT

Dr Peter Schulam, MD is a medicare enrolled "Urology" physician in New Haven, Connecticut. His current practice location is 20 York St, Np-4, Smilow Cancer Center - Ynhh, New Haven, Connecticut. You can reach out to his office (for appointments etc.) via phone at (203) 200-4822.

Dr Peter Schulam is licensed to practice in Connecticut (license number 50525) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1487674768.

Contact Information

Dr Peter Schulam, MD
20 York St, Np-4, Smilow Cancer Center - Ynhh,
New Haven, CT 06510-3202
(203) 200-4822
(203) 200-2099



Physician's Profile

Full NameDr Peter Schulam
GenderMale
SpecialityUrology
Location20 York St, Np-4, New Haven, Connecticut
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1487674768
  • Provider Enumeration Date: 07/20/2006
  • Last Update Date: 08/14/2012
  Medicare PECOS Information:
  • PECOS PAC ID: 0840321329
  • Enrollment ID: I20120305000208

Medical Identifiers

Medical identifiers for Dr Peter Schulam such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1487674768NPI-NPPES
00A714680MedicaidCA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208800000XUrology A71468 (California)Secondary
208800000XUrology 50525 (Connecticut)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Peter Schulam allows following entities to bill medicare on his behalf.
Entity NameYale University
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1205822236
PECOS PAC ID: 9436061736
Enrollment ID: O20031105000015

News Archive

RXi Pharmaceuticals reports positive results from 2 placebo-controlled double blind studies of RXI-109

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced the unblinded results of the first of their 2 placebo-controlled double blind studies in volunteers with their anti-scarring agent RXI-109, a proprietary sd-rxRNA compound that has been shown in vitro and in animals to reduce mRNA for connective tissue growth factor.

Unemployment will run out for 1.3 million as GOP again blocks jobless bill

The Associated Press: Slightly more than 1.3 million people won't get unemployment benefits reinstated before Congress goes on its July 4th recess and an "additional 200,000 people who have been without a job for at least six months stand to lose their benefits each week, unless Congress acts."

World becoming numb to HIV/AIDS: UNAIDS executive director

HIV infection is on the rise but there is potential to control the upsurge of infections with effective measures only if there are adequate funds. According to UNAIDS executive director Michel Sidibe the world has become numb to the fact that 7,400 people are being infected with AIDS every day and funds to combat it are not pouring in as they should. Since 2001, the number of newly infected people has fallen by 17 per cent a year - but there are still 2.7 million new cases each year.

Study assesses therapeutic benefits of new oral immunotherapy for children allergic to wheat

The study carried out by researchers from the Centre for Plant Biotechnology and Genomics along with the Allergy Department of the Hospital Infantil Universitario Niño Jesús of Madrid have shown that, most of the children that received this new oral immunotherapy treatment were able to eat 100 grams of wheat bread without side effects. This result has overcome the risk of accidental ingestion by patients with this allergy. This research could be the basis for large clinical trials with more patients with the aim of assessing the therapeutic benefit of this new approach.

Obama calls health law mandate a 'principle;' Supplement industry heavily funding Romney campaign

In an interview, the president seeks to find a way around the issue of whether the mandate is a tax or a penalty. Meanwhile, USA Today finds that individuals and companies with ties to the nutritional and dietary supplement industry have given $4.5 million to the GOP candidate.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Peter Schulam is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Peter Schulam, MD
P.o. Box 208041, Fmp 316, Yale School Of Medicine, Dept Of Urology,
New Haven, CT 06520-8041

Ph: (203) 785-2815
Dr Peter Schulam, MD
20 York St, Np-4, Smilow Cancer Center - Ynhh,
New Haven, CT 06510-3202

Ph: (203) 200-4822

News Archive

RXi Pharmaceuticals reports positive results from 2 placebo-controlled double blind studies of RXI-109

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced the unblinded results of the first of their 2 placebo-controlled double blind studies in volunteers with their anti-scarring agent RXI-109, a proprietary sd-rxRNA compound that has been shown in vitro and in animals to reduce mRNA for connective tissue growth factor.

Unemployment will run out for 1.3 million as GOP again blocks jobless bill

The Associated Press: Slightly more than 1.3 million people won't get unemployment benefits reinstated before Congress goes on its July 4th recess and an "additional 200,000 people who have been without a job for at least six months stand to lose their benefits each week, unless Congress acts."

World becoming numb to HIV/AIDS: UNAIDS executive director

HIV infection is on the rise but there is potential to control the upsurge of infections with effective measures only if there are adequate funds. According to UNAIDS executive director Michel Sidibe the world has become numb to the fact that 7,400 people are being infected with AIDS every day and funds to combat it are not pouring in as they should. Since 2001, the number of newly infected people has fallen by 17 per cent a year - but there are still 2.7 million new cases each year.

Study assesses therapeutic benefits of new oral immunotherapy for children allergic to wheat

The study carried out by researchers from the Centre for Plant Biotechnology and Genomics along with the Allergy Department of the Hospital Infantil Universitario Niño Jesús of Madrid have shown that, most of the children that received this new oral immunotherapy treatment were able to eat 100 grams of wheat bread without side effects. This result has overcome the risk of accidental ingestion by patients with this allergy. This research could be the basis for large clinical trials with more patients with the aim of assessing the therapeutic benefit of this new approach.

Obama calls health law mandate a 'principle;' Supplement industry heavily funding Romney campaign

In an interview, the president seeks to find a way around the issue of whether the mandate is a tax or a penalty. Meanwhile, USA Today finds that individuals and companies with ties to the nutritional and dietary supplement industry have given $4.5 million to the GOP candidate.

Read more News

› Verified 6 days ago


Urology Doctors in New Haven, CT

Dr. Thomas V. Martin, M.D.
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 330 Orchard St, Suite 164, New Haven, CT 06511
Phone: 203-789-2222    Fax: 203-624-3697
John W Colberg, MD
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 800 Howard Ave, Yale Physicians Building 3rd Floor, New Haven, CT 06519
Phone: 203-785-2815    Fax: 203-785-4043
Harris E Foster Jr., MD
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 800 Howard Avenue #318, New Haven, CT 06520
Phone: 203-785-2815    Fax: 203-785-4043
Dr. Gregory Lamont Lacy Ii, M.D.
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 800 Howard Ave, New Haven, CT 06519
Phone: 203-785-2815    Fax: 203-785-4043
Michael Howard Siev, MD
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 20 York St, New Haven, CT 06510
Phone: 203-688-4242    
Ralph J Devito, M.D.
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 330 Orchard St, Suite 164, New Haven, CT 06511
Phone: 203-789-2222    Fax: 203-624-3697
Dr. Israel Franco, MD
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 789 Howard Avenue,, Fmp 300, New Haven, CT 06520
Phone: 203-785-7671    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.